Ingram Prices Platinum Supply, Not the Buyback Floor

Ingram Micro Holding Corporation (INGM.US) closed at $25.72 on May 18, 2026, below the $26.00 secondary-offering price that Platinum Equity sold at on May 5, 2026 and well below the $28.04 last sale price cited in the launch prospectus on May 4, 2026. The market has treated the May block as fresh supply. It has not fully priced the two details that matter more: Ingram itself repeatedly buys sponsor paper, and the remaining sponsor stake is contractually frozen for 60 days unless the banks waive it. [2][3][6]

Opportunity Ranking

Rank	Idea	Discovery Lane	Why It May Be Best Now	Evidence Freshness	Catalyst Window	Asymmetry	Main Reason to Reject
1	Ingram Micro prices Platinum supply, not the buyback floor	U.S. / large-cap / sponsor overhang / secondary repurchase	Strong Q1, raised repurchase capacity, sponsor sold a block at $26.00, company simultaneously set up a roughly 1.20 million-share concurrent repurchase at the underwriters' purchase price, and the remaining sponsor stake is locked for 60 days	SEC 8-K and prospectus dated April 30 to May 7, 2026; live quote checked May 18, 2026 [1][2][3][4][6]	Block already cleared, 60-day lock-up expiry in early July, Q2 results in late July	The market marked the stock below the deal price even though no new shares were issued and the company itself was a buyer	Selected
2	Alfresa Holdings still trades as a distributor, not as a fresh ASR buyer	Japan / large-cap / buyback / healthcare distribution	Board authorized up to ¥15 billion of buybacks and completed a ToSTNeT-3 leg at ¥2,300 while the stock closed at ¥2,254.5 on May 18	Official and market reports dated May 15 to May 18, 2026; live quote checked May 18, 2026 [7][8]	Buyback adjustment mechanics and cancellation path through the summer	Clean capital-return signal with a stock below the execution price	Rejected. Valid, but upside looked narrower and the sourcing stack was thinner than Ingram's SEC trail
3	Times Electric cancellation is real, but the denominator change is still small	Broader Asia / Hong Kong / H-share buyback	The company cancelled 10.25 million repurchased H shares after spending HK$364.7 million, yet the stock still closed at HK$40.94 on May 18	HKEX announcement dated May 12, 2026; live quote checked May 18, 2026 [9][10]	Post-cancellation rerating and further repurchases	Repurchases are real and ongoing	Rejected. The cancellation changes the float, but not enough to dominate operating-cycle risk right now
4	Babcock prices the Type 31 charge, not the new buyback	Europe / UK / defense / buyback	FY26 brought a new £200 million buyback and stronger cash generation, while the stock closed at 975.0p on May 18	Company announcement and live quote dated May 13 to May 18, 2026 [11][12]	Execution on the buyback and the next trading update	Reasonable medium-term upside if the charge proves non-recurring	Rejected. Good setup, but the charge is still noisy enough that the thesis is less mechanically clean than Ingram

Selected opportunity: INGM.US

Why this one now: The market marked Ingram below the sponsor's public sale price even though the sale was non-dilutive, the company retired part of the block at the underwriters' lower purchase price, Q1 came in ahead of guide, Q2 guide still implies growth, and the remaining sponsor stake cannot immediately dump more stock without a waiver. [1][2][3]

What should surprise the reader: The block looked like supply, but it also contained a buyback floor. Ingram bought sponsor paper at $21.36 in March and then bought more sponsor paper at $24.96 in May. The company has been telling the market, twice, what price range it will absorb Platinum stock at. [2][3][4]

Geographic Search Audit

U.S. candidate screened: Ingram Micro. Selected.
Japan candidate screened: Alfresa Holdings. Rejected because the thesis is valid but less asymmetric and less primary-source-rich than Ingram.
Broader Asia candidate screened: Zhuzhou CRRC Times Electric. Rejected because the H-share cancellation is real but too small to dominate the operating story.
Europe / UK candidate screened: Babcock International. Rejected because the buyback thesis still competes with a live contract-charge overhang.

The Setup

Ingram Micro reported a strong first quarter on April 30, 2026. Net sales reached $14.0 billion, up 13.7% year over year. Gross profit rose to $926.0 million, up 11.7%. Non-GAAP diluted EPS was $0.75, at the high end of guidance, and the company lifted its quarterly dividend to $0.084 per share. Management then guided the second quarter to $13.6 billion to $14.0 billion of net sales and $0.68 to $0.78 of non-GAAP diluted EPS, which still implies year-over-year growth. [1]

The same release disclosed something more interesting than the quarter. In March, Ingram repurchased $75 million of stock directly from affiliates of Platinum at $21.36 per share. On April 30, the board raised the sponsor-secondary repurchase authorization from $100 million to $175 million, leaving $100 million available at that point. [1][4]

Five days later, Platinum launched a secondary sale of 12,740,384 shares at $26.00. Ingram itself did not issue any new shares and received none of the sale proceeds. Instead, it authorized a concurrent $30 million repurchase from the underwriters at the same price the underwriters paid Platinum, not the public price. Because the underwriting discount was $1.04 per share, that buyback price was effectively $24.96, which implies about 1.20 million shares retired if the repurchase closed as disclosed. [2][3]

The Mispricing

The market appears to have priced the May transaction as one more sponsor exit. That is the headline. It is not the full economics.

This was a non-dilutive secondary. No new shares were issued. Platinum sold stock. Ingram bought some of that stock back. The net effect is not 12.74 million new shares flooding the market. It is a smaller block transfer into public hands plus a simultaneous denominator shrink inside the company. [2][3]

The more important variant view is about sequencing and control.

As of the April 23 share count disclosed in the 10-Q, Ingram had 231,646,534 shares outstanding. Platinum beneficially owned 197,104,541 shares, or 85.1%, as of March 31. After the May sale, Platinum still owns roughly 80% of the company, depending on the final concurrent repurchase and any greenshoe exercise. That sounds like bad news. It is also what creates the opportunity. The remaining stake is still large enough to overhang sentiment, but the prospectus imposed a 60-day lock-up on the company, the selling stockholder, directors, and officers. The market is pricing future supply immediately even though the legal ability to dump more stock is temporarily shut. [2][4][5]

What the market is missing is not that Platinum will someday sell more. It probably will. What the market is missing is that Ingram has now twice demonstrated a willingness to be the bid on sponsor paper, first at $21.36, then at $24.96, while the business itself continues to print double-digit top-line growth and rising earnings. The public market is trading below the public offering price even though management itself was a price-sensitive buyer inside the transaction. [1][3][4]

Price

Metric	Value	Source
INGM close, May 18, 2026	$25.72	Stooq [6]
INGM open, May 18, 2026	$25.38	Stooq [6]
INGM high, May 18, 2026	$26.005	Stooq [6]
INGM low, May 18, 2026	$25.16	Stooq [6]
INGM volume, May 18, 2026	1,203,156	Stooq [6]
Last reported NYSE sale price before launch, May 4, 2026	$28.04	Final prospectus [2]
Public secondary offering price, May 5, 2026	$26.00	Offering press release / prospectus [2][3]
Underwriters' purchase price from Platinum	$24.96	Final prospectus, calculated from $26.00 less $1.04 discount [2]
Concurrent company repurchase	$30.0 million	Offering press release / prospectus [2][3]
Implied shares to be retired in the disclosed May repurchase	~1.20 million	Calculated from $30.0 million / $24.96 [2][3]
March sponsor-block repurchase	$75.0 million at $21.36	Q1 release / 10-Q [1][4]
Repurchase authorization after April 30 increase	$175.0 million total	Q1 release / 10-Q [1][4]
Remaining authorization before the May block closed	$100.0 million	Q1 release / 10-Q [1][4]
Q1 2026 net sales	$14.0 billion	Q1 release [1]
Q1 2026 gross profit	$926.0 million	Q1 release [1]
Q1 2026 non-GAAP diluted EPS	$0.75	Q1 release [1]
Q2 2026 non-GAAP diluted EPS guide	$0.68 to $0.78	Q1 release [1]
Cash and cash equivalents, March 28, 2026	$916.0 million	10-Q [4]

At $25.72, the stock sits 1.1% below the public offering price and 8.3% below the $28.04 pre-launch reference price used in the prospectus. The market has fully incorporated the supply event. It has not fully re-priced the fact that the company itself was shrinking the denominator inside that same event. [2][3][6]

Positioning

Positioning evidence is unusually concrete here.

Fact: Platinum still controlled the company. The May 15 Schedule 13G/A showed 197.1 million beneficially owned shares, or 85.1% of the company, as of March 31, 2026, based on the 231.65 million shares outstanding disclosed in the 10-Q. [4][5]

Fact: Ingram did not merely say the stock was attractive. It bought sponsor paper twice. First, $75 million at $21.36 on March 9. Then $30 million inside the May secondary at the underwriters' lower purchase price. [1][3][4]

Inference: The public market appears to have traded the May deal like generic sponsor leakage. That is plausible because the remaining stake is still very large and because many investors mechanically sell or fade sponsor blocks. This is inference, not a directly observed flow study.

Missing data: Live short interest, real-time block-buyer composition, and the exact greenshoe outcome were not directly verified in this run. Those matter for timing, but they do not change the core point that the sale was non-dilutive and partly retired.

Catalyst

There are three relevant clocks.

Catalyst 1: the block is already done. The offering priced on May 5 and closed around May 7. Once a sponsor block clears, the next question is whether the stock can trade without the rumor of imminent supply. That reset has already started. [2][3]

Catalyst 2: the 60-day lock-up freezes the next sale. The final prospectus states that the company, the selling stockholder, directors, and executive officers agreed not to sell or hedge shares for 60 days from the prospectus date, absent underwriter consent. That does not eliminate the overhang. It changes its timing. [2]

Catalyst 3: Q2 still has to validate the quarter. Management guided to $13.6 billion to $14.0 billion of net sales and $0.68 to $0.78 of non-GAAP diluted EPS for Q2. If that lands near the top end, the market will have to choose between treating Ingram as a growth-and-efficiency story or continuing to value it mainly as sponsor paper in motion. [1]

Payoff Map

Preferred expression: long common stock. The setup is fundamentally about block clearance, denominator shrink, and a still-frozen sponsor stake. Common stock captures that best without forcing an implied-volatility call.

Price Target and Probability Map

Scenario	Probability	Target / Level	Return / Payoff	Time Horizon	Conditions Required	Evidence Quality
Top Case	20%	$31.00	+20.5%	6 to 10 weeks	Q2 tracks near the top end of guide, no new sponsor leakage before the lock-up expires, and the market re-rates the name back above the pre-launch level	Medium
Base Case	55%	$28.50	+10.8%	4 to 10 weeks	The May block is absorbed, the market recognizes the non-dilutive structure and buyback floor, and the stock recovers toward the pre-launch range	High
Bottom Case	25%	$22.00	-14.5%	4 to 12 weeks	Another sponsor block is anticipated immediately after lock-up, Q2 misses, or AI mix pressure compresses margin harder than the market expects	Medium
Invalidation / Stop Condition	n/a	Below $21.00 on new fundamental negative	Thesis broken	Immediate once visible	Sponsor gets an early lock-up waiver, operating guide is cut, or the company stops defending the stock in future sponsor exits	High

Probability-weighted expected value: +6.4%

Current market price / level: $25.72 close on May 18, 2026 [6]

Timestamp: Stooq quote timestamp 22:00:20 on May 18, 2026 [6]

Primary instrument: INGM common stock

Alternative expressions considered: July or August call spreads can work, but live option-chain pricing was not verified in this run and the thesis does not require leverage.

Confidence: Medium-High

What Would Prove This Wrong

Platinum receives an early waiver and launches another block before the market finishes digesting the first one.
Q2 guidance is cut or the company prints below the lower end of its own range.
Management stops using repurchases to absorb sponsor exits, which would remove the clearest revealed-preference signal in the setup.
The stock breaks $21.00 on new fundamental information rather than on generic overhang chatter. That would put it through the March sponsor-buyback level and say the business thesis is deteriorating, not just the ownership base.

Risk Audit

Strongest counterargument: Platinum still owns about four-fifths of the company. The overhang is not solved. It is merely time-shifted.

Most fragile assumption: That the market will treat the concurrent repurchase as a valuation signal rather than as minor optics inside a much larger sponsor sell-down story.

What the market may already know: Sponsor exits are common, lock-ups expire, and public investors know more paper will likely come. The market may simply be discounting the next block early.

What could make the trade lose money even if the thesis is directionally right: A second block could hit immediately after the lock-up period, keeping the stock range-bound long enough that the thesis works in value but not in time.

Liquidity / execution risks: Common-stock liquidity is good. The bigger execution risk is event timing, not the tape.

Leverage risks: Not applicable to the preferred common-stock expression. Option structures add time-decay and implied-volatility risk without being necessary.

Information reliability risks: Low to medium. Core facts come from SEC filings and the Stooq quote feed. Missing items are live short-interest and options-positioning data.

Invalidation trigger: Early waiver plus new supply, or a business miss that forces the market to view March and May repurchases as value traps.

Publish / revise / reject recommendation: Publish.

Bottom Line

Ingram is not a hidden story. The numbers are public, the sponsor overhang is public, and the block trade was public. The mispricing sits in the order of importance. The market has centered the story on Platinum's desire to sell. It has underweighted the company's own willingness to buy that paper, the fact that the sale did not dilute holders, and the temporary legal freeze on more sponsor supply. At $25.72, below the public block price, the stock trades as though only the seller mattered. The filings show two buyers mattered: the market, and Ingram itself. [1][2][3][4]

Research Quality Scorecard

The canonical Research Quality Scorecard is preserved in the companion meta file: 2026-05-19-ingram-prices-platinum-not-buyback-meta.md

Sources

Best Trade Strategy

Best trade: Long INGM common stock. The clean expression is spot common because the setup is a non-dilutive sponsor block with an embedded buyback, a still-frozen seller, and a near-term earnings checkpoint. Options are secondary and should stay conditional on a live chain check.